Kbc Group Nv Vericel Corp Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Vericel Corp stock. As of the latest transaction made, Kbc Group Nv holds 1,483 shares of VCEL stock, worth $84,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,483

Previous 1,483 -0.0%

Holding current value

$84,916

Previous $68,000 7.35%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$41.71 - $52.9 $17,267 - $21,900	414 Added 38.73%	1,483 $68,000
Q1 2024 May 08, 2024	SELL	$32.52 - $52.33 $12,455 - $20,042	-383 Reduced 26.38%	1,069 $56,000
Q4 2023 Feb 13, 2024	SELL	$30.85 - $37.09 $60,435 - $72,659	-1,959 Reduced 57.43%	1,452 $52,000
Q3 2023 Feb 15, 2024	SELL	$31.69 - $39.25 $62,080 - $76,890	-1,959 Reduced 57.43%	1,452 $49,000
Q2 2023 Feb 15, 2024	SELL	$29.0 - $38.37 $28,333 - $37,487	-977 Reduced 22.27%	3,411 $128,000
Q2 2023 Jul 28, 2023	SELL	$29.0 - $38.37 $12,673 - $16,767	-437 Reduced 11.36%	3,411 $128,000
Q1 2023 Feb 14, 2024	SELL	$23.85 - $31.34 $12,879 - $16,923	-540 Reduced 12.31%	3,848 $113,000
Q1 2023 May 04, 2023	SELL	$23.85 - $31.34 $12,879 - $16,923	-540 Reduced 12.31%	3,848 $113,000
Q3 2022 Feb 15, 2024	BUY	$22.62 - $32.54 $66,412 - $95,537	2,936 Added 202.2%	4,388 $102,000
Q2 2022 Feb 14, 2024	SELL	$22.88 - $39.45 $204,478 - $352,564	-8,937 Reduced 67.07%	4,388 $110,000
Q2 2022 Jul 26, 2022	BUY	$22.88 - $39.45 $100,397 - $173,106	4,388 New	4,388 $110,000
Q1 2022 May 06, 2022	SELL	$31.69 - $43.29 $422,269 - $576,839	-13,325 Closed	0 $0
Q4 2021 Feb 14, 2024	BUY	$35.2 - $52.6 $417,929 - $624,519	11,873 Added 817.7%	13,325 $524,000
Q4 2021 Feb 03, 2022	BUY	$35.2 - $52.6 $360,729 - $539,044	10,248 Added 333.05%	13,325 $524,000
Q3 2021 Nov 10, 2021	BUY	$46.35 - $59.75 $142,618 - $183,850	3,077 New	3,077 $150,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.7B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account